11th #World #Congress on #Precision and #Personalized #Medicine

#August 14-15, 2019 #Auckland, #New Zealand

Why precision medicines for oncology demand precision engagement ???

The speed of scientific breakthroughs in precision medicine is leading to groundbreaking treatments, particularly in oncology and rare diseases. More than 85 percent of the oncology market is now focused on targeted therapies and the number of new oncology therapeutics in development in the U.S. alone has risen by 34 percent since 2015.  Oncology is an important beachhead for precision medicine due to efforts to understand how unique each patient is and how much the same disease can vary from patient to patient or over time within the same patient.

Innovation in this area has created an explosion of scientific information. In addition to data from clinical studies, real-world patient information is also growing rapidly in both volume and importance. For example, the responses of patient sub-populations, patient adherence data, preferences with treatment regimens, and other observations are vital for the larger understanding of precision medicine adoption, use, and optimization for better outcomes.